News & Updates
Filter by Specialty:

AD trial: Cognitive impairment exacerbated with reduced iron in brain
14 Nov 2024
byJairia Dela Cruz
Brain iron-lowering therapy with deferiprone appears to do more harm than good in patients with Alzheimer's disease (AD), being associated with increased cognitive decline in a phase II study.
AD trial: Cognitive impairment exacerbated with reduced iron in brain
14 Nov 2024
Excessive health anxiety, preoccupation with one’s health, and endless online searches in this regard have given rise to ‘Cyberchondria.’
14 Nov 2024
byProfessor Dr Bernard Fanthome
Cyberchondria is the new epidemic of the digital age.
Excessive health anxiety, preoccupation with one’s health, and endless online searches in this regard have given rise to ‘Cyberchondria.’
14 Nov 2024
Study pinpoints factors affecting cervical cancer screening participation in Singapore
13 Nov 2024
byJairia Dela Cruz
Cervical cancer screening uptake remains suboptimal in Singapore, with uptake influenced by demographic factors, screening knowledge and awareness, health-related belief and behaviour, according to a study.
Study pinpoints factors affecting cervical cancer screening participation in Singapore
13 Nov 2024
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
13 Nov 2024
byStephen Padilla
Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.